BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 22337949)

  • 21. Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C.
    Sobao Y; Tomiyama H; Nakamura S; Sekihara H; Tanaka K; Takiguchi M
    Hepatology; 2001 Jan; 33(1):287-94. PubMed ID: 11124847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral PD-1
    Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
    Front Immunol; 2019; 10():1470. PubMed ID: 31316516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
    Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
    J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.
    Grüner NH; Gerlach TJ; Jung MC; Diepolder HM; Schirren CA; Schraut WW; Hoffmann R; Zachoval R; Santantonio T; Cucchiarini M; Cerny A; Pape GR
    J Infect Dis; 2000 May; 181(5):1528-36. PubMed ID: 10823750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
    Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin.
    Boo I; Fischer AE; Johnson D; Chin R; Giourouki M; Bharadwaj M; Bowden S; Torresi J; Drummer H
    J Clin Virol; 2007 Aug; 39(4):288-94. PubMed ID: 17569577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C.
    Owusu Sekyere S; Suneetha PV; Kraft AR; Zhang S; Dietz J; Sarrazin C; Manns MP; Schlaphoff V; Cornberg M; Wedemeyer H
    J Hepatol; 2015 Jan; 62(1):31-40. PubMed ID: 25131771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of IL-10-secreting CD8
    Wang W; Tong Z; Zhong J; Zhang L; Zhang H; Su Y; Gao B; Zhang C
    Immunol Lett; 2018 Oct; 202():16-22. PubMed ID: 30055200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.
    Radziewicz H; Ibegbu CC; Fernandez ML; Workowski KA; Obideen K; Wehbi M; Hanson HL; Steinberg JP; Masopust D; Wherry EJ; Altman JD; Rouse BT; Freeman GJ; Ahmed R; Grakoui A
    J Virol; 2007 Mar; 81(6):2545-53. PubMed ID: 17182670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
    Wiegand J; Cornberg M; Aslan N; Schlaphoff V; Sarrazin C; Kubitschke A; Buggisch P; Ciner A; Jaeckel E; Manns MP; Wedemeyer H
    Antivir Ther; 2007; 12(3):303-16. PubMed ID: 17591020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
    Kasprowicz V; Schulze Zur Wiesch J; Kuntzen T; Nolan BE; Longworth S; Berical A; Blum J; McMahon C; Reyor LL; Elias N; Kwok WW; McGovern BG; Freeman G; Chung RT; Klenerman P; Lewis-Ximenez L; Walker BD; Allen TM; Kim AY; Lauer GM
    J Virol; 2008 Mar; 82(6):3154-60. PubMed ID: 18160439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection.
    Sreenarasimhaiah J; Jaramillo A; Crippin J; Lisker-Melman M; Chapman WC; Mohanakumar T
    Hum Immunol; 2003 May; 64(5):497-504. PubMed ID: 12691700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
    Pilli M; Zerbini A; Penna A; Orlandini A; Lukasiewicz E; Pawlotsky JM; Zeuzem S; Schalm SW; von Wagner M; Germanidis G; Lurie Y; Esteban JI; Haagmans BL; Hezode C; Lagging M; Negro F; Homburger Y; Neumann AU; Ferrari C; Missale G;
    Gastroenterology; 2007 Oct; 133(4):1132-43. PubMed ID: 17919489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in hepatitis C virus (HCV)-specific CD8 T-cell phenotype during pegylated alpha interferon and ribavirin treatment are related to response to antiviral therapy in patients chronically infected with HCV.
    Caetano J; Martinho A; Paiva A; Pais B; Valente C; Luxo C
    J Virol; 2008 Aug; 82(15):7567-77. PubMed ID: 18480446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.